The mechanism of action of probiotics

Purpose of review Probiotics are a heterogeneous group of nonpathologic bacteria that are functionally defined by their ability to allay inflammation when introduced into the inflamed intestine. The purpose of this review is to discuss recent data bearing on the possible mechanisms of action of these bacteria, with a particular focus on the relation of these mechanisms to the pathogenesis of inflammatory bowel disease, their main arena of use. Recent findings Studies of probiotic activity in recent years provide evidence that probiotics counter experimental and human gastrointestinal inflammation (human inflammatory bowel disease) by their effects on epithelial cell function, including epithelial cell barrier function, epithelial cytokine secretion, and their antibacterial effects relating to colonization of the epithelial layer. In addition, there is emerging evidence that probiotics induce regulatory T cells that act as a break on the effector T cells that would otherwise cause inflammation. Summary This review of probiotics and inflammatory bowel disease marshals support for the concept that administration of probiotics ameliorates inflammation by exerting positive effects on the epithelial cell dysfunction and mucosal immune system dysfunction that forms the basis of the inflammation.

[1]  F. Obermeier,et al.  Surface Expression of Toll-Like Receptor 9 Is Upregulated on Intestinal Epithelial Cells in Response to Pathogenic Bacterial DNA , 2007, Infection and Immunity.

[2]  M. Weichenthal,et al.  Reduced Paneth cell alpha-defensins in ileal Crohn's disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Le Shen,et al.  A porous defense: the leaky epithelial barrier in intestinal disease , 2004, Laboratory Investigation.

[4]  M. Weichenthal,et al.  Reduced Paneth cell α-defensins in ileal Crohn's disease , 2005 .

[5]  A. Fanning,et al.  Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius , 2006, Immunology.

[6]  Laurent Beaugerie,et al.  High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. , 2004, Gastroenterology.

[7]  O. Dewit,et al.  Multicenter randomized‐controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after ileo‐caecal resection , 2007 .

[8]  D. Graham,et al.  Review article: Mycobacterium avium subsp. paratuberculosis as one cause of Crohn's disease. , 2001, Alimentary pharmacology & therapeutics.

[9]  D. Hommes,et al.  Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dendritic cell function. , 2004, The American journal of clinical nutrition.

[10]  R. Hershberg The epithelial cell cytoskeleton and intracellular trafficking. V. Polarized compartmentalization of antigen processing and Toll-like receptor signaling in intestinal epithelial cells. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[11]  M. Gotteland,et al.  Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori? , 2006, Alimentary pharmacology & therapeutics.

[12]  Tomohiro Watanabe,et al.  Signalling pathways and molecular interactions of NOD1 and NOD2 , 2006, Nature Reviews Immunology.

[13]  S. Colgan,et al.  Apical secretion of a pathogen-elicited epithelial chemoattractant activity in response to surface colonization of intestinal epithelia by Salmonella typhimurium. , 1998, Journal of immunology.

[14]  T. Tompkins,et al.  Probiotics Reduce Enterohemorrhagic Escherichia coli O157:H7- and Enteropathogenic E. coli O127:H6-Induced Changes in Polarized T84 Epithelial Cell Monolayers by Reducing Bacterial Adhesion and Cytoskeletal Rearrangements , 2005, Infection and Immunity.

[15]  K. Madsen,et al.  Probiotics and prebiotics in gastrointestinal disorders , 2004, Current opinion in gastroenterology.

[16]  G. Vinderola,et al.  Role of Intestinal Epithelial Cells in Immune Effects Mediated by Gram-Positive Probiotic Bacteria: Involvement of Toll-Like Receptors , 2005, Clinical Diagnostic Laboratory Immunology.

[17]  M. Selsted,et al.  Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. , 2000, Nature immunology.

[18]  D. Graham,et al.  Mycobacterium avium subsp. paratuberculosis as one cause of Crohn’s disease , 2001 .

[19]  J. Coppee,et al.  Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. , 2006, The Journal of Immunology.

[20]  M. Zeitz,et al.  Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. , 2005, Gastroenterology.

[21]  L. van Lieshout,et al.  Pouchitis: result of microbial imbalance? , 1994, Gut.

[22]  M. Yazdanbakhsh,et al.  Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. , 2005, The Journal of allergy and clinical immunology.

[23]  K. Madsen,et al.  Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. , 1999, Gastroenterology.

[24]  D. D. Jong,et al.  NOD 2 mediates anti-inflammatory signals induced byTLR 2 ligands : implications for Crohn ’ s disease , 2004 .

[25]  J. Bertin,et al.  CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. , 2001, EMBO reports.

[26]  H. Qin,et al.  Effect of lactobacillus on the gut microflora and barrier function of the rats with abdominal infection. , 2005, World journal of gastroenterology.

[27]  J. Coppee,et al.  Anti-Inflammatory Effect of Lactobacillus casei on Shigella-Infected Human Intestinal Epithelial Cells1 , 2006, The Journal of Immunology.

[28]  J. Bertin,et al.  CARD4/Nod1 mediates NF‐κB and JNK activation by invasive Shigella flexneri , 2001 .

[29]  C. Pothoulakis,et al.  Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression. , 2006, Biochemical and biophysical research communications.

[30]  P. Rutgeerts,et al.  Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. , 1998, Gastroenterology.

[31]  J. Chang,et al.  Lactobacillus plantarum inhibits epithelial barrier dysfunction and interleukin-8 secretion induced by tumor necrosis factor-alpha. , 2007, World journal of gastroenterology.

[32]  D. Haller,et al.  Innate mechanisms for Bifidobacterium lactis to activate transient pro‐inflammatory host responses in intestinal epithelial cells after the colonization of germ‐free rats , 2005, Immunology.

[33]  J. Gordon,et al.  Inflammatory Bowel Disease and Adenomas in Mice Expressing a Dominant Negative N-Cadherin , 1995, Science.

[34]  T. Giese,et al.  Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. , 2005, Gastroenterology.

[35]  E. Schiffrin,et al.  Induction by a Lactic Acid Bacterium of a Population of CD4+ T Cells with Low Proliferative Capacity That Produce Transforming Growth Factor β and Interleukin-10 , 2001, Clinical Diagnostic Laboratory Immunology.

[36]  R. Sartor,et al.  Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment , 2000, Gut.

[37]  S. Akira,et al.  Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. , 2004, Gastroenterology.

[38]  Hidde L Ploegh,et al.  CX3CR1-Mediated Dendritic Cell Access to the Intestinal Lumen and Bacterial Clearance , 2005, Science.

[39]  M. Kleerebezem,et al.  Towards understanding molecular modes of probiotic action. , 2006, Current opinion in biotechnology.

[40]  J. Söderholm,et al.  Chronic stress induces mast cell-dependent bacterial adherence and initiates mucosal inflammation in rat intestine. , 2002, Gastroenterology.

[41]  M. Jakobsen,et al.  Interactions of macrophages with probiotic bacteria lead to increased antiviral response against vesicular stomatitis virus. , 2007, Antiviral research.

[42]  M. Abreu,et al.  TLR Signaling in the Gut in Health and Disease1 , 2005, The Journal of Immunology.

[43]  I. Autenrieth,et al.  Identification of Commensal Bacterial Strains That Modulate Yersinia enterocolitica and Dextran Sodium Sulfate-Induced Inflammatory Responses: Implications for the Development of Probiotics , 2007, Infection and Immunity.

[44]  J. Neu,et al.  Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-alpha-induced interleukin-8 production in Caco-2 cells. , 2005, The Journal of nutrition.

[45]  E. Mayer,et al.  The neurobiology of stress and gastrointestinal disease , 2000, Gut.

[46]  G. Ruthel,et al.  Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[47]  F. Brennan,et al.  IL-10 gene therapy prevents TNBS-induced colitis , 2002, Gene Therapy.

[48]  D. Haller,et al.  IL-10 Gene-Deficient Mice Lack TGF-β/Smad Signaling and Fail to Inhibit Proinflammatory Gene Expression in Intestinal Epithelial Cells after the Colonization with Colitogenic Enterococcus faecalis1 , 2005, The Journal of Immunology.

[49]  A. Macpherson,et al.  Interactions between commensal intestinal bacteria and the immune system , 2004, Nature Reviews Immunology.

[50]  Tomohiro Watanabe,et al.  NOD2 is a negative regulator of Toll-like receptor 2–mediated T helper type 1 responses , 2004, Nature Immunology.

[51]  C. De Simone,et al.  Probiotic bacteria enhance murine and human intestinal epithelial barrier function. , 2001, Gastroenterology.

[52]  H. Kiyono,et al.  Oral feeding of Bifidobacterium bifidum (BGN4) prevents CD4(+) CD45RB(high) T cell-mediated inflammatory bowel disease by inhibition of disordered T cell activation. , 2007, Clinical immunology.

[53]  Mourad Sahbatou,et al.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.

[54]  C. Dejong,et al.  Strain-Specific Effects of Probiotics on Gut Barrier Integrity following Hemorrhagic Shock , 2005, Infection and Immunity.

[55]  M Schwab,et al.  NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression , 2004, Gut.

[56]  Ruslan Medzhitov,et al.  Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis , 2004, Cell.

[57]  F. Shanahan,et al.  Probiotic effects on inflammatory bowel disease. , 2007, The Journal of nutrition.

[58]  K. Barrett,et al.  Probiotics and Commensals Reverse TNF-α– and IFN-γ–Induced Dysfunction in Human Intestinal Epithelial Cells , 2003 .

[59]  D. McKay,et al.  Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress , 2006, Gut.

[60]  M. Washington,et al.  Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. , 2007, Gastroenterology.

[61]  R. Sartor,et al.  Probiotic therapy of intestinal inflammation and infections , 2005, Current opinion in gastroenterology.

[62]  J. Söderholm,et al.  Stress and gastrointestinal tract. II. Stress and intestinal barrier function. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[63]  R. Geffers,et al.  The host response to the probiotic Escherichia coli strain Nissle 1917: Specific up-regulation of the proinflammatory chemokine MCP-1 , 2005, BMC Medical Genetics.

[64]  John Bertin,et al.  Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island , 2004, Nature Immunology.

[65]  W. Strober,et al.  Insights into the Mechanism of Oral Tolerance Derived from the Study of Models of Mucosal Inflammation , 2004, Annals of the New York Academy of Sciences.

[66]  K. Madsen,et al.  Probiotics and nutraceuticals: non-medicinal treatments of gastrointestinal diseases. , 2005, Current opinion in pharmacology.

[67]  K. Takeda,et al.  Interleukin‐12 is involved in the enhancement of human natural killer cell activity by Lactobacillus casei Shirota , 2006, Clinical and experimental immunology.

[68]  P. Scully,et al.  Differential cytokine response from dendritic cells to commensal and pathogenic bacteria in different lymphoid compartments in humans. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[69]  R. Blumberg,et al.  The immunology of mucosal models of inflammation. , 2002, Annual review of immunology.

[70]  K. Fellermann,et al.  Induction of Human β-Defensin 2 by the Probiotic Escherichia coli Nissle 1917 Is Mediated through Flagellin , 2007, Infection and Immunity.

[71]  R. Greenstein Is Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease. , 2003, The Lancet. Infectious diseases.

[72]  F. Caprioli,et al.  Lactobacillus paracasei subsp. paracasei B21060 Suppresses Human T-Cell Proliferation , 2007, Infection and Immunity.

[73]  J. Sirard,et al.  A Key Role of Dendritic Cells in Probiotic Functionality , 2007, PloS one.

[74]  G. Reid,et al.  G‐CSF‐mediated inhibition of JNK is a key mechanism for Lactobacillus rhamnosus‐induced suppression of TNF production in macrophages , 2006, Cellular microbiology.

[75]  P. Felsburg,et al.  Different cytokine response of primary colonic epithelial cells to commensal bacteria. , 2005, World journal of gastroenterology.

[76]  Jongdae Lee,et al.  Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. , 2002, Gastroenterology.

[77]  M. Marinaro,et al.  Probiotics Ameliorate Recurrent Th1-Mediated Murine Colitis by Inducing IL-10 and IL-10-Dependent TGF-β-Bearing Regulatory Cells1 , 2005, The Journal of Immunology.

[78]  B. Lacy,et al.  The Interrelated Roles of TGF-β and IL-10 in the Regulation of Experimental Colitis , 2002, The Journal of Immunology.

[79]  J. Söderholm,et al.  Increased antigen and bacterial uptake in follicle associated epithelium induced by chronic psychological stress in rats , 2004, Gut.

[80]  Tomohiro Watanabe,et al.  Following the TRAIL from hepatitis C virus and alcohol to fatty liver , 2005, Gut.

[81]  J. Cheville,et al.  Absence of Mycobacterium avium subspecies paratuberculosis components from Crohn's disease intestinal biopsy tissues. , 2003, Clinical medicine & research.

[82]  G. Bouma,et al.  The immunological and genetic basis of inflammatory bowel disease , 2003, Nature Reviews Immunology.

[83]  B. Franke,et al.  NOD2 mediates anti‐inflammatory signals induced by TLR2 ligands: implications for Crohn's disease , 2004, European journal of immunology.

[84]  S. Collins Stress and the Gastrointestinal Tract IV. Modulation of intestinal inflammation by stress: basic mechanisms and clinical relevance. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[85]  Beatrice Vitali,et al.  Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. , 2003, FEMS immunology and medical microbiology.

[86]  L. Eckmann,et al.  Amendment history : Corrigendum ( April 2005 ) Toll-like receptor 9 – induced type I IFN protects mice from experimental colitis , 2018 .

[87]  L. Matrisian,et al.  Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. , 1999, Science.

[88]  A. Darfeuille‐Michaud,et al.  Lactobacillus casei DN-114 001 Inhibits the Ability of Adherent-Invasive Escherichia coli Isolated from Crohn's Disease Patients To Adhere to and To Invade Intestinal Epithelial Cells , 2005, Applied and Environmental Microbiology.

[89]  J. Pestka,et al.  Lactobacilli Differentially Modulate Expression of Cytokines and Maturation Surface Markers in Murine Dendritic Cells1 , 2002, The Journal of Immunology.

[90]  F. Shanahan,et al.  Role of interleukin (IL‐10) in probiotic‐mediated immune modulation: an assessment in wild‐type and IL‐10 knock‐out mice , 2006, Clinical and experimental immunology.

[91]  P. Brigidi,et al.  Modulation of human dendritic cell phenotype and function by probiotic bacteria , 2004, Gut.

[92]  M. Schmidt,et al.  Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO‐2 and PKCζ redistribution resulting in tight junction and epithelial barrier repair , 2007, Cellular microbiology.

[93]  F. Guarner,et al.  Lactobacillus casei prevents the upregulation of ICAM-1 expression and leukocyte recruitment in experimental colitis. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[94]  A. Levine,et al.  Maturation of the mucosal immune system underlies colitis susceptibility in interleukin‐10‐deficient (IL‐10−/−) mice , 2007, Journal of leukocyte biology.